Ligand Pharmaceuticals CLO, Secretary Andrew Reardon disposes of $1.5 million in common shares
LGND•Ligand Pharmaceuticals CLO and Secretary Andrew Reardon sold 5,000 common shares at weighted-average prices of $302.5107 to $307.74 on Oct. 2, 2026, reducing his stake to 31,854 shares.
1. Share sales
Reardon exercised 340 employee stock options at $52.27, bringing his direct holdings to 36,854 shares before the sales. He then sold 5,000 shares, leaving him with 31,854 shares.
